Skip to main content

Non invasive early cervical cancer screening and detection

This device will be an easy to use, at home, HPV marker detection test.

Project Overview

Cervical cancer is one of the most common cancers in women and also is one of the most treatable cancers when diagnosed early. Current cervical cancer screenings include Pap smears and HPV (human papillomavirus) tests. Testing methods such as the Pap smear must be collected by a medical professional, as it requires cells to be collected from the surface of the cervix and vagina. While these tests are somewhat successful at detecting cervical cancer, they are not easily accessible for people in developing countries and can be an uncomfortable experience. The development of a discrete self-collected urine sample test would increase early cervical cancer detection by providing a cost-effect and culturally sensitive screening option. This device would allow cervical cancer screenings to be easily accessible worldwide, which in turn would prevent many cervical cancer-related deaths.

Team Picture

Team Picture
Team Picture


Contact Information

Team Members

  • Georgia Hancock - Team Leader
  • Mira Baichoo - Communicator
  • Josephine Hall - BSAC
  • Adrienne Simpson - Co-BWIG
  • Cora Williams - Co-BWIG
  • Karina Buttram - BPAG

Advisor and Client

  • Dr. Tongcheng Qian - Advisor
  • Ms. Kebron Zegeye - Client
Back to Top